"Thymidine Phosphorylase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine.
| Descriptor ID |
D013939
|
| MeSH Number(s) |
D08.811.913.400.725.850.500 D23.050.301.500.600.925 D23.050.705.552.600.850
|
| Concept/Terms |
Thymidine Phosphorylase- Thymidine Phosphorylase
- Platelet-Derived Endothelial Cell Growth Factor
- Platelet Derived Endothelial Cell Growth Factor
- PD-ECGF
- Gliostatin
|
Below are MeSH descriptors whose meaning is more general than "Thymidine Phosphorylase".
Below are MeSH descriptors whose meaning is more specific than "Thymidine Phosphorylase".
This graph shows the total number of publications written about "Thymidine Phosphorylase" by people in this website by year, and whether "Thymidine Phosphorylase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thymidine Phosphorylase" by people in Profiles.
-
Layman RM, Thomas DG, Griffith KA, Smerage JB, Helvie MA, Roubidoux MA, Diehl KM, Newman LA, Sabel MS, Hayman JA, Pierce LJ, Hayes DF, Schott AF. Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer. Clin Cancer Res. 2007 Jul 15; 13(14):4092-7.
-
Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006 Nov 20; 24(33):5313-27.
-
Meropol NJ, Gold PJ, Diasio RB, Andria M, Dhami M, Godfrey T, Kovatich AJ, Lund KA, Mitchell E, Schwarting R. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer. J Clin Oncol. 2006 Sep 1; 24(25):4069-77.